Answers are grounded in this paper and cite their sources.
Because procainamide hydrochloride (Pronestyl) may block neuromuscular transmission (NMT), this drug is contraindicated in cases of myasthenia gravis. Reduction of the safety factor of NMT is also seen in other conditions, including peripheral neuropathies. A patient with uremic peripheral neuropathy in whom myasthenia-like weakness developed during procainamide therapy is described. Procainamide should be given with caution in cases of peripheral neuropathies in which there may be a reduction of the safety factor of NMT.
No takes yet. Share an insight, caveat, or question.
Niakan et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: